BC can be categorized into four different subtypes based on the expression of the Human epidermal growth factor receptor (HER2/neu), the estrogen receptor (ER), and the progesterone receptor (PR): triple negative breast cancer (TNBC), Luminal A, Luminal B, and HER2 (+). Here, ERBB2 is linked to triple-negative breast carcinoma.